CN Patent

CN113735879B — 一种大环jak抑制剂及其应用

Assigned to Baiji Hongye Guangdong Pharmaceutical Technology Co ltd · Expires 2022-05-17 · 4y expired

What this patent protects

本发明涉及一种大环JAK抑制剂及其应用。具体地，本发明涉及如式I所示的化合物或其立体异构体或光学异构体、药学上可接受的盐、前药或溶剂化物，也涉及所述化合物的药物组合物以及其作为JAK抑制剂，以及在制备预防和/或治疗与JAK，尤其是JAK3相关疾病的药物中的医药用途。

USPTO Abstract

本发明涉及一种大环JAK抑制剂及其应用。具体地，本发明涉及如式I所示的化合物或其立体异构体或光学异构体、药学上可接受的盐、前药或溶剂化物，也涉及所述化合物的药物组合物以及其作为JAK抑制剂，以及在制备预防和/或治疗与JAK，尤其是JAK3相关疾病的药物中的医药用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN113735879B
Jurisdiction
CN
Classification
—
Expires
2022-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Baiji Hongye Guangdong Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.